Back
Back
The Ketogenic Diet in a Pill
Official Title
Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy
Study Details
The purpose of the study is to see if SGLT2i can replace a ketogenic diet as epilepsy treatment.
Principal Investigator
Dr. K. Liu Lin Thio
IRB Number
202005031
Eligibility
1. Participants must be 18 to 45 years of age
2. Participants must have epilepsy
Volunteer Information
For more information about this study, contact Volunteer for Health at:
- 314.362.1000
- rprstaff@wustl.edu